PFE Pfizer, Inc. Common Stock
$25,95
Fiyat · May 20, 2026
Temel veriler itibarıyla May 5, 2026
52 Haftlık Aralık
$23–$29
53% of range
Analist Derecelendirmesi
HOLD
36 analysts
Fiyat Hedefi
$29
+12% upside
P/E (TTM)
18.3
ROE
8.9%
Net Kâr Marjı
12.4%
PFE Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$25.95
Piyasa Değeri
—
P/E (TTM)
18.3
EPS (TTM)
$1.36
Gelir (TTM)
$62.58B
Temettü Verimi
—
ROE
8.9%
D/E Borç/Özsermaye
0.7
52 Haftlık Aralık
$23 – $29
PFE Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$62.58B
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$1.36
2016-12-31
→
2025-12-31
Serbest Nakit Akışı
$9.07B
2016-12-31
→
2025-12-31
Marjlar
12.4%
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
PFE
Akran Ortalaması
P/E (TTM)
18.3
19.4
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
PFE
Akran Ortalaması
Net Profit Margin (Net Kâr Marjı)
12.4%
14.6%
ROA
3.7%
4.0%
ROE
8.9%
10.1%
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
PFE
Akran Ortalaması
Debt / Equity (Borç / Öz Sermaye)
0.7
139.5
Current Ratio (Cari Oran)
1.2
1.6
Quick Ratio (Cari Oran)
0.4
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
PFE
Akran Ortalaması
Revenue YoY (Gelir Yıllık Bazda)
-1.7%
—
Revenue CAGR 3Y (Gelir 3 Yıllık Bileşik Büyüme Oranı)
-14.8%
—
Revenue CAGR 5Y (Gelir 5 Yıllık Bileşik Büyüme Oranı)
8.5%
—
EPS YoY (EPS YB)
-3.5%
—
Net Income YoY (Net Gelir Yıllık Bazda)
-3.2%
—
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
PFE
Akran Ortalaması
Temettüler Temettü verimi, ödeme oranı, temettü geçmişi, 5 Yıllık CAGR
Temettü Verimi
—
Temettü Ödeme Oranı
—
5 Yıllık Temettü CAGR
—
| Ex-tarihi | Miktar |
|---|---|
| 08 Mayıs 2026 | $0,4300 |
| 23 Ocak 2026 | $0,4300 |
| 07 Kasım 2025 | $0,4300 |
| 25 Temmuz 2025 | $0,4300 |
| 09 Mayıs 2025 | $0,4300 |
| 24 Ocak 2025 | $0,4300 |
| 08 Kasım 2024 | $0,4200 |
| 26 Temmuz 2024 | $0,4200 |
| 09 Mayıs 2024 | $0,4200 |
| 25 Ocak 2024 | $0,4200 |
| 09 Kasım 2023 | $0,4100 |
| 27 Temmuz 2023 | $0,4100 |
| 11 Mayıs 2023 | $0,4100 |
| 26 Ocak 2023 | $0,4100 |
| 03 Kasım 2022 | $0,4000 |
| 28 Temmuz 2022 | $0,4000 |
| 12 Mayıs 2022 | $0,4000 |
| 27 Ocak 2022 | $0,4000 |
| 04 Kasım 2021 | $0,3900 |
| 29 Temmuz 2021 | $0,3900 |
PFE Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
TUT
36 analist
- Güçlü Al 5 13,9%
- Al 11 30,6%
- Tut 17 47,2%
- Sat 2 5,6%
- Güçlü Sat 1 2,8%
12 Aylık Fiyat Hedefi
27 analist · 2026-05-18
Medyan
$28.00
Ortalama
$29.19
Şimdi
$25.95
Düşük
$24.00
Yüksek
$36.00
Medyan hedef
$28.00
+7,9%
Ortalama hedef
$29.19
+12,5%
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
0.16%
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 31 Mart 2026 | $0.75 | $0.72 | 0.03% |
| 31 Aralık 2025 | $0.66 | $0.58 | 0.08% |
| 30 Eylül 2025 | $0.87 | $0.64 | 0.23% |
| 30 Haziran 2025 | $0.78 | $0.59 | 0.19% |
| 31 Mart 2025 | $0.92 | $0.67 | 0.25% |
Eş Karşılaştırması Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| PFE | — | 18.3 | -1.7% | 12.4% | 8.9% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
| JNJ | — | 18.8 | 6.0% | 28.5% | 35.0% | 67.9% |
| MRK | — | 14.5 | 1.3% | 28.1% | 36.9% | — |
| BMY | — | 15.6 | -0.22% | 14.6% | 40.5% | — |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | — |
| RPRX | — | 21.7 | 5.1% | 32.4% | 8.0% | — |
| VTRS | — | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | — |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $62.58B | $63.63B | $59.55B | $101.17B | $81.29B | $41.65B | $40.91B | $40.83B | · | $52.55B | $52.82B | $48.85B | |
| Cost of Revenue | $16.07B | $17.85B | $24.95B | $34.34B | $30.82B | $8.48B | $8.05B | $8.99B | · | $11.23B | $12.32B | $9.65B | |
| SG&A Expense | $13.79B | $14.73B | $14.77B | $13.68B | $12.70B | $11.60B | $12.73B | $12.61B | · | $14.80B | $14.84B | $14.81B | |
| Interest Expense | $2.67B | $3.09B | $2.21B | $1.24B | $1.29B | $1.45B | $1.57B | $1.32B | · | $1.27B | $1.19B | $1.20B | |
| Interest Income | $603M | $545M | $1.62B | $251M | $36M | $73M | $225M | $333M | · | $391M | $470M | $471M | |
| Other Non-op | $-6.72B | $-4.39B | $-222M | $-1.06B | $4.88B | $-1.21B | $-3.50B | $-2.08B | · | $-1.42B | $-3.79B | $-2.86B | |
| Pretax Income | $7.52B | $8.02B | $1.06B | $34.73B | $24.31B | $7.04B | $11.32B | $3.59B | · | $12.30B | $8.35B | $8.96B | |
| Income Tax | $-266M | $-28M | $-1.11B | $3.33B | $1.85B | $370M | $583M | $-266M | · | $-9.05B | $1.12B | $1.99B | |
| Net Income | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B | $9.16B | $16.03B | $11.15B | · | $21.31B | $7.21B | $6.96B | |
| EPS (Basic) | $1.37 | $1.42 | $0.38 | $5.59 | $3.92 | $1.65 | $2.88 | $1.90 | · | $3.57 | $1.18 | $1.13 | |
| EPS (Diluted) | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 | $1.63 | $2.82 | $1.87 | · | $3.52 | $1.17 | $1.11 | |
| Shares (Basic) | 5,683,000,000 | 5,664,000,000 | 5,643,000,000 | 5,608,000,000 | 5,601,000,000 | 5,555,000,000 | 5,569,000,000 | 5,872,000,000 | · | 5,970,000,000 | 6,089,000,000 | 6,176,000,000 | |
| Shares (Diluted) | 5,713,000,000 | 5,700,000,000 | 5,709,000,000 | 5,733,000,000 | 5,708,000,000 | 5,632,000,000 | 5,675,000,000 | 5,977,000,000 | · | 6,058,000,000 | 6,159,000,000 | 6,257,000,000 | |
| EBITDA | $6.59B | $7.01B | $6.29B | $5.06B | $5.19B | · | $6.01B | $6.38B | · | $6.27B | $5.76B | $5.16B |
Bilanço 29
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.14B | $1.04B | $2.85B | $416M | $1.94B | $1.79B | $1.12B | $1.14B | · | $1.34B | $2.60B | $3.64B | |
| Short-term Investments | · | · | · | · | · | $10.44B | $8.53B | $17.69B | · | $18.65B | $15.26B | $19.65B | |
| Receivables | $11.87B | $11.46B | $11.57B | $10.95B | $11.48B | $7.91B | $6.77B | $8.03B | $8.23B | $8.22B | $8.22B | $8.18B | |
| Inventory | $10.65B | $10.85B | $10.19B | $8.98B | $9.06B | $8.02B | $7.07B | $7.51B | $7.57B | $7.58B | $6.78B | $7.51B | |
| Other Current Assets | $2.81B | $4.25B | $4.91B | $5.02B | $3.82B | $3.65B | $2.36B | $2.46B | · | $2.29B | $2.25B | $2.15B | |
| Current Assets | $42.90B | $50.36B | $43.33B | $51.26B | $59.69B | $35.07B | $32.80B | $49.93B | · | $41.14B | $38.95B | $43.80B | |
| PP&E (Net) | $19.32B | $18.39B | $18.94B | $16.27B | $14.88B | $13.74B | $12.97B | $13.38B | · | $13.87B | $13.32B | $13.77B | |
| PP&E (Gross) | $36.70B | $34.88B | $34.98B | $31.45B | $29.95B | $28.41B | $27.96B | $29.98B | · | $30.04B | $28.12B | $27.27B | |
| Accum. Depreciation | $17.39B | $16.48B | $16.05B | $15.17B | $15.07B | $14.66B | $14.99B | $16.59B | · | $16.17B | $14.81B | $13.50B | |
| Goodwill | $71.26B | $68.53B | $67.78B | $51.38B | $49.21B | $49.56B | $48.18B | $42.93B | · | $55.95B | $54.45B | $48.24B | |
| Intangibles | $53.73B | $55.41B | $64.90B | $43.37B | $25.15B | $28.34B | $33.94B | $35.21B | · | $48.74B | $52.65B | $40.36B | |
| Other Non-current Assets | $9.63B | $9.82B | $12.47B | $13.16B | $7.68B | $4.88B | $4.20B | $2.80B | $3.02B | $3.23B | $3.32B | $3.42B | |
| Total Assets | $208.16B | $213.40B | $226.50B | $197.21B | $181.48B | $154.23B | $167.59B | $159.42B | · | $172.00B | $171.62B | $167.38B | |
| Accounts Payable | $5.24B | $5.63B | $6.71B | $6.81B | $5.58B | $4.28B | $3.89B | $4.67B | · | $4.66B | $4.54B | $3.62B | |
| Short-term Debt | $0 | $2.45B | $7.96B | $0 | $0 | $556M | $13.91B | $3.10B | · | $6.10B | $5.80B | · | |
| Current Liabilities | $36.98B | $42.99B | $47.79B | $42.14B | $42.67B | $25.92B | $37.30B | $31.86B | · | $30.43B | $31.11B | $29.40B | |
| Capital Leases | $2.29B | $2.29B | $2.63B | $2.60B | $2.51B | $1.11B | $1.03B | · | · | · | · | · | |
| Deferred Tax | $2.40B | $2.12B | $640M | $1.02B | $349M | $4.06B | $5.65B | $3.70B | $3.99B | $3.90B | $30.75B | $26.88B | |
| Other Non-current Liabilities | $14.72B | $14.15B | $16.54B | $13.18B | $9.74B | $6.67B | $6.89B | $5.85B | $5.69B | $6.15B | $6.34B | $5.26B | |
| Total Liabilities | $121.39B | $124.90B | $137.21B | $101.29B | $104.01B | $90.76B | $104.15B | $95.66B | · | $100.14B | $111.78B | $102.38B | |
| Long-term Debt | $64.64B | $61.15B | $63.79B | $35.44B | $37.83B | $4.00B | $37.42B | $37.69B | · | $37.08B | $31.40B | $28.82B | |
| Total Debt | $64.64B | $63.60B | $71.76B | $35.44B | $37.83B | $39.69B | $51.33B | $40.78B | · | $43.18B | $35.62B | $32.54B | |
| Common Stock | $481M | $480M | $478M | $476M | $473M | $470M | $468M | $467M | · | $464M | $461M | $459M | |
| Paid-in Capital | $94.47B | $93.60B | $92.63B | $91.80B | $90.59B | $88.67B | $87.43B | $86.25B | · | $84.28B | $82.69B | $81.02B | |
| Retained Earnings | $114.61B | $116.72B | $118.35B | $125.66B | $103.39B | $90.39B | $97.67B | $89.55B | $86.47B | $85.29B | $71.77B | $71.99B | |
| Treasury Stock | $115.02B | $114.76B | $114.49B | $113.97B | $111.36B | $110.99B | $110.80B | $101.61B | · | $89.42B | $84.36B | $79.25B | |
| AOCI | $-8.07B | $-7.84B | $-7.96B | $-8.30B | $-5.90B | $-5.31B | $-11.64B | $-11.28B | $-10.23B | $-9.32B | $-11.04B | $-9.52B | |
| Stockholders' Equity | $86.48B | $88.20B | $89.01B | $95.66B | $77.20B | $63.24B | $63.14B | $63.41B | · | $71.31B | $59.54B | $64.72B | |
| Liabilities + Equity | $208.16B | $213.40B | $226.50B | $197.21B | $181.48B | $154.23B | $167.59B | $159.42B | · | $171.80B | $171.62B | $167.38B |
Nakit Akışı 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $6.59B | $7.01B | $6.29B | $5.06B | $5.19B | $4.68B | $5.75B | $6.38B | · | $6.27B | $5.76B | $5.16B | |
| Stock-based Comp | $799M | $877M | $525M | $872M | $1.18B | $755M | $687M | $923M | · | $840M | $691M | $669M | |
| Deferred Tax | $-2.13B | $-2.10B | $-3.44B | $-3.76B | $-4.29B | $-1.57B | $561M | $-2.20B | · | $-2.41B | $-700M | $-20M | |
| Amort. of Intangibles | · | $5.30B | $4.70B | $3.60B | $3.70B | $3.40B | $4.50B | · | · | · | · | $3.80B | |
| Restructuring | $1.09B | $1.99B | $1.97B | $882M | $741M | $535M | $227M | $796M | · | $30M | $1.05B | $811M | |
| Other Non-cash | $-1.32B | $-1.07B | $3.21B | $-4.28B | $8.52B | · | $-11.03B | $-454M | · | $-9.54B | $2.94B | $1.75B | |
| Operating Cash Flow | $11.70B | $12.74B | $8.70B | $29.27B | $32.58B | $14.40B | $12.59B | $15.83B | · | $16.80B | $16.19B | $14.69B | |
| CapEx | $2.63B | $2.91B | $3.91B | $3.24B | $2.71B | $2.23B | $2.05B | $1.98B | · | $1.96B | $1.82B | $1.40B | |
| Investing Cash Flow | $-1.35B | $2.65B | $-32.28B | $-15.78B | $-22.55B | $-4.27B | $-3.94B | $4.53B | · | $-4.74B | $-7.79B | $-2.98B | |
| Debt Issued | $9.68B | $0 | $30.83B | $0 | $997M | $5.22B | $4.94B | $4.97B | · | $5.27B | $10.98B | $0 | |
| Net Debt Issued | $2.92B | $-2.25B | $28.26B | $-3.30B | $-1.01B | $1.22B | $-1.86B | $1.41B | · | $-880M | $3.29B | $-3.00B | |
| Stock Repurchased | · | $0 | $0 | $2.00B | $0 | $0 | $8.87B | $12.20B | · | $5.00B | $5.00B | $6.16B | |
| Net Stock Activity | · | $0 | $0 | $-2.00B | $0 | $0 | $-8.87B | $-12.20B | · | $-5.00B | $-5.00B | $-6.16B | |
| Financing Cash Flow | $-10.30B | $-17.14B | $26.07B | $-14.83B | $-9.82B | $-9.65B | $-8.48B | $-20.44B | · | $-13.35B | $-9.23B | $-10.41B | |
| Net Change in Cash | $91M | $-1.81B | $2.45B | $-1.51B | $159M | $475M | $125M | $-205M | · | $-1.24B | $-1.04B | $298M | |
| Taxes Paid | $4.69B | $3.60B | $3.15B | $7.87B | $7.43B | $3.15B | $3.66B | $3.65B | · | $2.49B | $2.52B | $2.38B | |
| Free Cash Flow | $9.07B | $9.84B | $4.79B | $26.03B | $29.87B | $12.15B | $10.41B | $13.79B | · | $14.51B | $14.08B | $13.12B | |
| Levered FCF | $6.31B | $6.73B | $256M | $24.91B | $28.68B | $10.79B | $8.96B | $12.55B | · | $12.31B | $13.05B | $12.18B |
Kârlılık 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 12.4% | 12.6% | 3.6% | 31.3% | 27.0% | 22.9% | 31.4% | 20.8% | · | 40.6% | 13.7% | 14.2% | |
| Pretax Margin | 12.0% | 12.6% | 1.8% | 34.6% | 29.9% | 17.9% | 34.2% | 22.1% | · | 23.4% | 15.8% | 18.4% | |
| EBITDA Margin | 10.5% | 11.0% | 10.8% | 5.1% | 6.4% | · | 11.6% | 11.9% | · | 11.9% | 10.9% | 10.6% | |
| ROA | 3.7% | 3.6% | 1.0% | 16.6% | 13.1% | 6.0% | 10.0% | 6.7% | · | 12.4% | 4.3% | 4.2% | |
| ROE | 8.9% | 9.1% | 2.3% | 36.3% | 31.3% | 15.2% | 25.7% | 16.6% | · | 32.6% | 11.6% | 10.2% |
Likidite ve Solventlik 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | 1.2 | 0.9 | 1.2 | 1.4 | 1.4 | 0.9 | 1.6 | · | 1.4 | 1.3 | 1.5 | |
| Quick Ratio | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.5 | 0.8 | · | 0.9 | 0.8 | 1.1 | |
| Debt / Equity | 0.7 | 0.7 | 0.8 | 0.4 | 0.5 | 0.6 | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.7 | 0.3 | 0.5 | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 0.4 |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | 0.3 | 0.5 | 0.5 | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | |
| Inventory Turnover | 1.5 | 1.7 | 2.6 | 3.8 | 3.6 | 1.2 | 1.3 | 1.5 | · | 1.6 | 1.7 | 1.5 | |
| Receivables Turnover | 5.4 | 5.5 | 5.3 | 8.9 | 8.4 | 5.7 | 6.2 | 6.6 | · | 6.4 | 6.4 | 5.9 |
Büyüme Oranları 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.7% | 6.8% | -41.1% | 24.5% | 95.2% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -14.8% | -7.8% | 12.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 8.5% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -3.5% | 281.1% | -93.2% | 42.1% | 136.2% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -37.1% | -28.4% | -39.0% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.6% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -3.2% | 279.0% | -93.2% | 42.7% | 140.0% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -37.2% | -28.5% | -38.6% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -3.2% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $62.58B | $63.63B | $59.55B | $101.17B | $81.29B | $41.65B | $40.91B | $40.83B | · | $52.55B | $52.82B | $48.85B | |
| Net Income TTM | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B | $9.16B | $16.03B | $11.15B | · | $21.31B | $7.21B | $6.96B | |
| P/E | 18.3 | 18.8 | 77.8 | 9.4 | 15.3 | 22.6 | 13.2 | 22.1 | · | 9.8 | 26.3 | 27.6 | |
| Earnings Yield | 5.5% | 5.3% | 1.3% | 10.7% | 6.5% | 4.4% | 7.6% | 4.5% | · | 10.2% | 3.8% | 3.6% |
Gelir Tablosu 14
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $14.45B | $17.56B | $16.65B | $14.65B | $13.71B | $17.76B | $17.70B | $13.28B | $14.88B | $14.57B | $13.49B | $13.01B | $18.49B | $25.14B | $22.64B | $27.74B | |
| Cost of Revenue | $3.55B | $5.27B | $4.17B | $3.78B | $2.85B | $5.91B | $5.26B | $3.30B | $3.38B | $7.56B | $9.27B | $3.24B | $4.89B | $9.65B | $6.06B | $8.65B | |
| SG&A Expense | $2.96B | $4.16B | $3.19B | $3.42B | $3.03B | $4.27B | $3.24B | $3.72B | $3.50B | $4.58B | $3.28B | $3.50B | $3.42B | $4.64B | $3.39B | $3.05B | |
| Interest Expense | $668M | $711M | $652M | $654M | $654M | $740M | $783M | $778M | $790M | $688M | $695M | $508M | $318M | $313M | $311M | $293M | |
| Interest Income | $115M | $166M | $138M | $156M | $143M | $170M | $116M | $130M | $129M | $609M | $523M | $316M | $177M | $137M | $70M | $30M | |
| Other Non-op | $-861M | $-4.51B | $-517M | $-739M | $-953M | $-2.36B | $-243M | $-1.11B | $-680M | $159M | $-181M | $75M | $-275M | $1M | $59M | $-772M | |
| Pretax Income | $3.17B | $-1.64B | $3.33B | $3.04B | $2.79B | $-10M | $4.71B | $-103M | $3.42B | $-4.13B | $-3.35B | $2.27B | $6.27B | $5.23B | $9.00B | $11.45B | |
| Income Tax | $461M | $-2M | $-216M | $141M | $-189M | $-421M | $234M | $-134M | $293M | $-795M | $-964M | $-71M | $715M | $230M | $356M | $1.57B | |
| Net Income | $2.69B | $-1.65B | $3.54B | $2.91B | $2.97B | $410M | $4.46B | $41M | $3.12B | $-3.37B | $-2.38B | $2.33B | $5.54B | $4.99B | $8.61B | $9.91B | |
| EPS (Basic) | $0.47 | $-0.28 | $0.62 | $0.51 | $0.52 | $0.07 | $0.79 | $0.01 | $0.55 | $-0.59 | $-0.42 | $0.41 | $0.98 | $0.88 | $1.54 | $1.77 | |
| EPS (Diluted) | $0.47 | $-0.29 | $0.62 | $0.51 | $0.52 | $0.07 | $0.78 | $0.01 | $0.55 | $-0.59 | $-0.42 | $0.41 | $0.97 | $0.87 | $1.51 | $1.73 | |
| Shares (Basic) | 5,691,000,000 | -11,362,000,000 | 5,685,000,000 | 5,685,000,000 | 5,675,000,000 | -11,326,000,000 | 5,667,000,000 | 5,666,000,000 | 5,657,000,000 | 1,000,000 | 5,646,000,000 | 5,646,000,000 | 5,634,000,000 | 2,000,000 | 5,607,000,000 | 5,593,000,000 | |
| Shares (Diluted) | 5,731,000,000 | -11,417,000,000 | 5,714,000,000 | 5,706,000,000 | 5,710,000,000 | -11,398,000,000 | 5,705,000,000 | 5,696,000,000 | 5,697,000,000 | -5,000,000 | 5,646,000,000 | 5,713,000,000 | 5,727,000,000 | 4,000,000 | 5,718,000,000 | 5,712,000,000 | |
| EBITDA | $1.61B | · | $1.66B | $1.62B | $1.62B | · | · | · | $1.74B | · | · | · | · | · | · | · |
Bilanço 28
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.70B | $1.14B | $1.34B | $1.64B | $1.43B | $1.04B | $1.09B | $1.05B | $719M | · | $3.15B | $2.63B | $2.17B | · | $1.30B | $1.78B | |
| Receivables | $12.59B | $11.87B | $14.26B | $12.08B | $11.85B | $11.46B | $14.45B | $11.39B | $10.99B | · | $11.09B | $10.23B | $12.30B | · | $16.08B | $15.15B | |
| Inventory | $10.67B | $10.65B | $11.47B | $11.67B | $10.85B | $10.85B | $11.72B | $11.45B | $10.89B | · | $10.20B | $10.31B | $9.54B | · | $9.51B | $10.45B | |
| Other Current Assets | $2.91B | $2.81B | $2.36B | $2.69B | $2.95B | $4.25B | $3.85B | $4.19B | $4.37B | · | $4.62B | $4.83B | $5.12B | · | $6.15B | $5.97B | |
| Current Assets | $42.82B | $42.90B | $46.92B | $43.70B | $45.86B | $50.36B | $43.22B | $37.83B | $42.41B | · | $74.01B | $73.35B | $50.08B | · | $70.40B | $67.47B | |
| PP&E (Net) | $19.40B | $19.32B | $18.88B | $18.78B | $18.35B | $18.39B | $18.54B | $18.96B | $18.80B | · | $17.86B | $17.49B | $17.05B | · | $15.44B | $15.24B | |
| PP&E (Gross) | · | $36.70B | · | · | · | $34.88B | · | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $17.80B | $17.39B | $17.50B | $17.27B | $16.84B | $16.48B | $16.68B | $16.57B | $16.36B | · | $15.78B | $15.55B | $15.51B | · | $14.93B | $14.97B | |
| Goodwill | $71.41B | $71.26B | $69.10B | $69.00B | $68.44B | $68.53B | $68.57B | $68.44B | $69.30B | $67.78B | $51.53B | $51.57B | $51.48B | $51.38B | $49.44B | $49.89B | |
| Intangibles | $52.56B | $53.73B | $51.32B | $52.70B | $53.98B | $55.41B | $59.99B | $61.24B | $62.83B | · | $40.22B | $41.41B | $42.00B | · | $28.15B | $29.07B | |
| Other Non-current Assets | $9.83B | $9.63B | $9.32B | $9.46B | $9.85B | $9.82B | $10.49B | $10.71B | $11.20B | · | $8.81B | $13.03B | $12.96B | · | $10.89B | $7.66B | |
| Total Assets | $207.62B | $208.16B | $208.73B | $206.09B | $208.03B | $213.40B | $219.48B | $216.19B | $221.09B | · | $215.02B | $220.17B | $195.62B | · | $195.35B | $195.29B | |
| Accounts Payable | $4.51B | $5.24B | $5.02B | $5.17B | $5.24B | $5.63B | $5.31B | $5.11B | $5.59B | · | $5.34B | $6.08B | $6.12B | · | $6.27B | $6.21B | |
| Short-term Debt | · | $0 | $0 | $0 | $155M | $2.45B | $5.84B | $7.96B | $6.93B | · | · | · | · | · | · | · | |
| Current Liabilities | $34.35B | $36.98B | $36.60B | $37.73B | $36.45B | $42.99B | $43.21B | $43.82B | $40.50B | · | $31.14B | $34.65B | $36.56B | · | $44.31B | $47.41B | |
| Capital Leases | · | $2.29B | · | · | · | $2.29B | · | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $2.41B | $2.40B | $2.47B | $2.48B | $2.26B | $2.12B | $2.16B | $2.23B | $931M | · | $1.12B | $1.23B | $1.07B | · | $616M | $558M | |
| Other Non-current Liabilities | $14.20B | $14.72B | $13.61B | $13.93B | $13.30B | $14.15B | $15.57B | $16.09B | $15.12B | · | $14.24B | $13.40B | $13.01B | · | $12.24B | $11.31B | |
| Total Liabilities | $117.21B | $121.39B | $115.64B | $117.08B | $117.39B | $124.90B | $126.92B | $128.22B | $128.54B | · | $117.82B | $120.88B | $94.38B | · | $102.46B | $107.82B | |
| Long-term Debt | $64.43B | $64.64B | $61.66B | $61.75B | $61.39B | $61.15B | $61.75B | $61.25B | $62.31B | · | $63.31B | $64.92B | $35.27B | · | $35.20B | $35.57B | |
| Total Debt | $64.43B | · | $61.66B | $61.75B | $61.54B | · | $67.59B | $69.22B | $69.24B | · | · | · | · | · | · | · | |
| Common Stock | $482M | $481M | $481M | $481M | $481M | $480M | $480M | $480M | $480M | · | $478M | $478M | $478M | · | $476M | $476M | |
| Paid-in Capital | $94.77B | $94.47B | $94.25B | $94.05B | $93.86B | $93.60B | $93.48B | $93.20B | $93.00B | · | $92.50B | $92.33B | $92.15B | · | $91.36B | $91.18B | |
| Retained Earnings | $117.24B | $114.61B | $121.15B | $117.61B | $119.59B | $116.72B | $121.06B | $116.60B | $121.32B | · | $126.41B | $128.80B | $131.10B | · | $122.97B | $116.61B | |
| Treasury Stock | $115.19B | $115.02B | $115.01B | $115.01B | $115.01B | $114.76B | $114.76B | $114.76B | $114.75B | · | $114.48B | $114.48B | $114.47B | · | $113.94B | $113.94B | |
| AOCI | $-7.20B | $-8.07B | $-8.07B | $-8.44B | $-8.58B | $-7.84B | $-7.97B | $-7.82B | $-7.76B | · | $-7.97B | $-8.10B | $-8.29B | · | $-8.22B | $-7.12B | |
| Stockholders' Equity | $90.10B | $86.48B | $92.80B | $88.69B | $90.34B | $88.20B | $92.29B | $87.70B | $92.28B | · | $96.93B | $99.02B | $100.97B | · | $92.63B | $87.21B | |
| Liabilities + Equity | $207.62B | $208.16B | $208.73B | $206.09B | $208.03B | $213.40B | $219.48B | $216.19B | $221.09B | · | $215.02B | $220.17B | $195.62B | · | $195.35B | $195.29B |
Nakit Akışı 18
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.61B | $1.69B | $1.66B | $1.62B | $1.62B | $1.79B | $1.75B | $1.73B | $1.74B | $1.67B | $1.56B | · | $1.49B | $1.52B | $1.18B | · | |
| Stock-based Comp | $272M | $225M | $201M | $203M | $170M | $177M | $274M | $206M | $220M | $121M | $151M | · | $105M | $364M | $135M | · | |
| Deferred Tax | $-12M | $-433M | $-765M | $-272M | $-663M | $-396M | $-482M | $-783M | $-441M | $-1.86B | $-113M | · | $-598M | $-365M | $62M | · | |
| Amort. of Intangibles | · | · | $1.20B | $1.20B | $1.20B | · | $1.30B | $1.30B | $1.30B | · | $1.20B | · | · | · | · | · | |
| Restructuring | $49M | $308M | $237M | $-74M | $621M | $656M | $217M | $1.10B | $10M | $1.80B | $71M | $138M | $-44M | $514M | $177M | $147M | |
| Other Non-cash | $-3.68B | · | · | · | $-3.68B | · | · | · | $-6.88B | · | · | · | · | · | · | · | |
| Operating Cash Flow | $2.62B | $5.35B | $4.60B | $-582M | $2.33B | $6.72B | $6.71B | $-1.78B | $1.09B | $5.24B | $3.46B | · | $1.21B | $8.58B | $5.97B | · | |
| CapEx | $436M | $845M | $602M | $618M | $564M | $917M | $651M | $637M | $704M | $1.04B | $810M | · | $1.14B | $1.00B | $841M | · | |
| Investing Cash Flow | $785M | $-6.15B | $-2.43B | $3.95B | $3.27B | $-1.62B | $-2.06B | $4.60B | $1.73B | $-11.00B | $888M | · | $3.31B | $-4.41B | $-627M | · | |
| Debt Issued | · | $5.99B | $0 | · | · | $0 | $0 | · | · | $0 | $0 | · | · | $0 | $0 | · | |
| Net Debt Issued | · | · | · | · | $0 | · | · | · | $-1.25B | · | · | · | $-269M | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | $0 | · | $0 | $0 | $0 | · | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | · | · | · | $0 | · | · | · | |
| Financing Cash Flow | $-2.86B | $596M | $-2.48B | $-3.20B | $-5.23B | $-5.11B | $-4.64B | $-2.46B | $-4.93B | $5.44B | $-3.78B | · | $-2.77B | $-5.01B | $-5.76B | · | |
| Net Change in Cash | $563M | $-196M | $-301M | $213M | $375M | $-45M | $29M | $343M | $-2.14B | $-316M | $535M | · | $1.75B | $-869M | $-487M | · | |
| Taxes Paid | $72M | $1.02B | $178M | $3.34B | $152M | $433M | $486M | $2.50B | $184M | $240M | $882M | · | $329M | $2.95B | $1.82B | · | |
| Free Cash Flow | $2.18B | · | · | · | $1.77B | · | · | · | $386M | · | · | · | $73M | · | · | · | |
| Levered FCF | $1.61B | · | · | · | $1.07B | · | · | · | $-336M | · | · | · | $-209M | · | · | · |
Kârlılık 5
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 18.6% | · | 21.3% | 19.9% | 21.6% | · | 25.2% | 0.31% | 20.9% | · | -18.0% | 18.3% | 30.3% | · | 38.0% | 35.7% | |
| Pretax Margin | 21.9% | · | 20.0% | 20.8% | 20.3% | · | 26.6% | -0.78% | 23.0% | · | -25.3% | 17.8% | 34.3% | · | 39.8% | 41.3% | |
| EBITDA Margin | 11.2% | · | 10.0% | 11.1% | 11.8% | · | · | · | 11.7% | · | · | · | · | · | · | · | |
| ROA | 1.3% | · | 1.7% | 1.4% | 1.4% | · | 2.1% | 0.02% | 1.5% | · | · | · | · | · | · | · | |
| ROE | 3.0% | · | 3.8% | 3.3% | 3.2% | · | 4.7% | 0.04% | 3.2% | · | · | · | · | · | · | · |
Likidite ve Solventlik 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.2 | · | 1.3 | 1.2 | 1.3 | · | 1.0 | 0.9 | 1.0 | · | · | · | · | · | · | · | |
| Quick Ratio | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.3 | 0.3 | · | · | · | · | · | · | · | |
| Debt / Equity | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.8 | 0.8 | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.7 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.7 | 0.7 | · | · | · | · | · | · | · |
Verimlilik 3
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | · | · | · | · | · | · | |
| Inventory Turnover | 0.3 | · | 0.4 | 0.3 | 0.3 | · | 0.5 | 0.3 | 0.3 | · | · | · | · | · | · | · | |
| Receivables Turnover | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.4 | 1.2 | 1.3 | · | · | · | · | · | · | · |
Değerleme (TTM) 4
| Metrik | Eğilim | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $59.47B | · | $62.72B | $59.35B | $59.58B | · | $59.35B | $54.66B | $59.86B | · | $67.62B | $81.87B | $94.53B | · | $100.08B | $96.34B | |
| Net Income TTM | $12.11B | · | $13.88B | $10.38B | $10.59B | · | $5.24B | $3.10B | $8.60B | · | $14.10B | $26.38B | $31.92B | · | $34.52B | $31.48B | |
| P/E | 12.8 | · | 9.8 | 13.3 | 13.6 | · | 31.6 | 50.9 | 18.4 | · | 13.4 | 7.9 | 7.3 | · | 7.3 | 9.5 | |
| Earnings Yield | 7.8% | · | 10.2% | 7.5% | 7.4% | · | 3.2% | 2.0% | 5.4% | · | 7.4% | 12.6% | 13.7% | · | 13.8% | 10.5% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $62.58B | $63.63B | $59.55B | $101.17B | $81.29B |
| Net Gelir | $7.77B | $8.03B | $2.12B | $31.37B | $21.98B |
| Seyreltilmiş Hisse Başı Kâr | $1.36 | $1.41 | $0.37 | $5.47 | $3.85 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.7 | 0.7 | 0.8 | 0.4 | 0.5 |
| Cari Oran | 1.2 | 1.2 | 0.9 | 1.2 | 1.4 |
| Cari Oran | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $9.07B | $9.84B | $4.79B | $26.03B | $29.87B |
Son Haberler Bu şirketten bahseden son manşetler
- 100 Doların Altında Alabileceğiniz 3 Derinlemesine Değersiz Hisse Senedi
- Rigel Pharma, Arvinas Ve Pfizer Arasında Veppanu İçin Lisans Anlaşması İmzaladı
- 3 Sağlık Hissesi Her Emeklinin Göz Önünde Bulundurması Gerekenler
- Tarih, Bu 3 Hissedeki Büyük Bir Düzeltmenin Yakın Olduğunu Gösteriyor
- Pfizer'ın %6'lık Temettü Verimi Güvenli mi? Yatırımcıların Bilmesi Gerekenler.
- Purdue Pharma'nın kriminal opioid davasında $225 milyon ceza ödemesi bekleniyor
- QSM Varlık Yönetimi, Düşük Performans Gösteren Manpower Group'a Yeni 5,9 Milyon Dolarlık Hisse Senedi Konumu Koydu
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.